Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LYEL compared with VIR: revenue, margins and what each company keeps, and the suppliers and customers both name
LYEL
Lyell Immunopharma, Inc.
Change
Mkt cap
Revenue
Revenue
VIR
Vir Biotechnology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LYEL
Lyell Immunopharma, Inc.
vs
VIR
Vir Biotechnology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
LYEL
Lyell Immunopharma, Inc.
Change
11.06
▲
+1.65%
Mkt cap
$266.6M
Revenue
$4,000
Q2 FY26
Revenue
$36,000
FY25
VIR
Vir Biotechnology, Inc.
Change
11.31
▲
+2.79%
Regular session
Nov 3 '26
Mkt cap
$1.9B
Revenue
$239M
Q2 FY26
Revenue
$74M
FY24
vs
Compare
Regular session
Nov 3 '26
LYEL
Lyell Immunopharma, Inc.
vs
VIR
Vir Biotechnology, Inc.
11.06
▲
+1.65%
Price
11.31
▲
+2.79%
$266.6M
Mkt cap
$1.9B
Q2 FY26
$4,000
Revenue
$239M
Q2 FY26
FY25
$36,000
Revenue
$74M
FY24
Change
Change
LYEL
11.06
▲
+1.65%
vs
VIR
11.31
▲
+2.79%
Regular session
Nov 3 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
LYEL: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LYEL
11
—
City of Hope Comprehensive Cancer Center
unlisted
supplier
—
Dana Farber Cancer Institute
unlisted
supplier
—
Innovative Cellular Therapeutics Holdings Limited and Innovative Cellular Therapeutics, Inc. (together, ICT)
unlisted
supplier
—
Miltenyi CliniMACS PRODIGY ®
unlisted
supplier
7 more · LYEL chain
›
Shared
0
No shared counterparties.
Only VIR
8
ALNY
Alnylam
supplier
XNCR
Xencor
supplier
SNY
Sanofi
supplier
—
Astellas
unlisted
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
customer
4 more · VIR chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LYEL, solid
VIR, dashed